文献速递免疫规划传染病防控与疫情报告

以干酪乳杆菌为载体的口服益生菌疫苗可有效增强草鱼对GCRV感染的防御

An oral probiotic vaccine loaded by Lactobacillus casei effectively increases defense against GCRV infection in grass carp.
PubMed 文献 · Vaccine · 2024-12-26

研究以草鱼呼肠孤病毒(GCRV)外衣壳蛋白VP5为免疫原、pVE5523为分泌表达载体构建重组干酪乳杆菌LC-pVE5523-VP5,经真空冷冻干燥制成菌粉并拌料压粒后口服免疫草鱼。免疫组免疫相关基因表达上调、血清IgM随免疫时间升高,攻毒后免疫组存活率74%显著高于对照组35%,组织病毒含量显著低于未免疫组,免疫15天后肠道仍可检出该重组菌。

要点

  • 免疫相关基因(IFN I、IgM等)在口服重组干酪乳杆菌菌粉饲料后显著上调
  • 攻毒后免疫组存活率74%显著高于对照组35%,组织病毒量显著低于未免疫组
  • 免疫15天后鱼肠道中仍可检出LC-pVE5523-VP5

核心结论

  • 口服LC-pVE5523-VP5能有效保护草鱼抵抗GCRV感染。

研究设计与样本

  • 以GCRV外衣壳蛋白VP5为免疫原、pVE5523为分泌表达载体构建重组LC-pVE5523-VP5,发酵液经真空冷冻干燥制成菌粉,与饲料混合后压制成颗粒,对草鱼口服免疫并开展GCRV攻毒存活分析。

主要发现

  • 口服重组干酪乳杆菌菌粉饲料后,草鱼免疫相关基因(IFN I、IgM等)表达显著上调。
  • 随口服免疫时间延长,草鱼血清IgM水平升高。
  • GCRV攻毒后免疫组存活率74%,显著高于对照组35%。
  • 免疫组鱼组织病毒含量显著少于未免疫组。
  • 免疫15天后鱼肠道中仍存在LC-pVE5523-VP5。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For a long time, grass carp culture in China has been severely affected by Grass Carp hemorrhagic disease caused by Grass Carp Reovirus (GCRV). At present, vaccines have been widely used for protecting aquatic organisms against infectious diseases, among which oral immunization with Lactobacillus casei is safe and highly effective. This vaccination route has the advantages of easy administration and noninvasive delivery. In this study, the recombinant LC-pVE5523-VP5 was constructed by using the outer capsid protein VP5 of GCRV as the immunogen and pVE5523 as the secretory expression vector. The bacterial powder was prepared from fermented broth by using the vacuum freeze-drying technology. The dried bacterial powder was subsequently mixed with feed and then pressed to pellets. After oral administration of the feed mixed with the recombinant L.casei powder, the expression of the immune-related genes (IFN I, IgM et al.) in grass carp was upregulated significantly. With the increased duration of oral immunization period, serum IgM level was also increased in grass carp. The survival analysis was carried out on the basis of grass carp in response to GCRV challenge. The result showed that the survival rate in the immunized group (74 %) was significantly higher than that in the control group (35 %). The amount of virus replication was also investigated in vaccine-treated fish. The result suggested that the virus content in fish tissue was also significantly less than that of the non-immunized group. The LC-pVE5523-VP5 was still present in the fish intestines 15 days after vaccination. These results indicated that the oral LC-pVE5523-VP5 can effectively protect grass carps from GCRV infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Zhao K, Liu Y, et al. An oral probiotic vaccine loaded by Lactobacillus casei effectively increases defense against GCRV infection in grass carp. Vaccine. 2024. PMID: 39729770. doi:10.1016/j.vaccine.2024.126660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。